K.Nagaraju Revised's Insider Trades & SAST Disclosures

Visit FAQs

K.Nagaraju Revised's most recent trade in Aurobindo Pharma Ltd. was a Acquisition of 7,000 Equity Shares done at an average price of Rs. 462.3 . Disclosure was reported to the exchange on May 26, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.

No reported SAST transactions available for K.Nagaraju Revised in the Trendlyne database.

Add Superstar Alert
Stock Client Name Client Category Action* Reported To/By Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Period Regulation (Insider/SAST) Security Type Mode
Aurobindo Pharma
K.Nagaraju (Revised) Other Acquisition 26 May 2023 7,000 14,800 (0%) 0.00% 462.3 3,235,960 06 Mar 2023
09 Mar 2023		 Insider Trading Equity Shares Market Purchase
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal. 
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal. 
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.
View All The Insider Trades & SAST